Keiji Mashimo

RANKL-induced c-Src activation contributes to conventional anti-cancer drug resistance and dasatinib overcomes this resistance in RANK-expressing multiple myeloma cells

Keiji Mashimo, Masanobu Tsubaki, T. Takeda, 2018, Clinical and Experimental Medicine.

Efficacy of a Side Hole-type Plastic Needle for Dissolving Abraxane®

Keiji Mashimo, D. Hira, M. Kakumoto, 2020, Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences).

Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study

Kaori Ito, Shota Suzuki, H. Miyata, 2023, International Journal of Clinical Oncology.

RANKL-induced c-Src activation contributes to conventional anti-cancer drug resistance and dasatinib overcomes this resistance in RANK-expressing multiple myeloma cells

Keiji Mashimo, T. Takeda, Ryota Asano, 2018, Clinical and Experimental Medicine.